Principal Members

1987 Graduated from Keio University School of Medicine
1993 Graduated from Keio University Faculty of Letters
1994 Ph.D of Medical Science
1996 Graduated from Keio University Faculty of Law
1999 Registered with Tokyo Bar Association (TMI Associates)
2001 Founded GBS Research Institute (the first startup from Keio University School of Medicine) and became the CEO
2005 Completed MBA at the University of Oxford Business School
2007 Appointed as a professor at Keio University Law School and School of Medicine (Surgery)
2020 Co-founded iXgene and became the CEO (Co-founder)
I also serve as an external director and advisor for several other startups.

In 2003, I completed the Department of Life Sciences and Informatics at the Tokyo Institute of Technology (Engineering Doctor). After serving as the Head of Research and Development, Business Development, and Administration for two pharmaceutical startups and one drug discovery support startup, I engaged in practical utilization of outstanding intellectual property from universities at companies such as JSR Corporation, two independent venture capital firms, and a strategic consulting firm. In 2020, I assumed the role of COO at iXgene (Co-founder)

1987 Graduated from Keio University School of Medicine
1995 Research Fellow in Neurosurgery at Georgetown University
2001 Co-founded GBS Research Institute (the first startup from Keio University School of Medicine)
2008 Department of Neurosurgery at University of Pittsburgh (sent from Keio University)
2020 Professor at Keio University School of Medicine (Department of Neurosurgery)
2020 Co-founded iXgene (Co-founder)

Completed the master’s program at the Graduate School of Pharmaceutical Sciences, Chiba University (1991), and obtained a Ph.D. (2003).
1991 Joined Yamanouchi Pharmaceutical Co., Ltd. (now Astellas Pharma Inc.) Engaged in drug discovery, contributed to the creation of marketed drugs (avatrombopag), and several developmental compound candidates. Also involved in the establishment of regenerative medicine research, leading research on genetically modified cells.
2019 Appointed as the Research and Development Director at Heartseed Corporation.
2020 Became the Cellular Medicine Department Director at Bright Path Bio Corporation.
2023 Joined iXgene Corporation as the Research and Development Director.

1983 Graduated from Keio University School of Medicine
1988 Completed the doctoral program at Keio University School of Medicine (Medical Doctor)
1989 Research Fellow at Johns Hopkins University School of Medicine
1996 Professor of Molecular Neurobiology in the Department of Basic Medical Sciences at the University of Tsukuba
1997 Professor in the Department of Neurofunctional Anatomy at Osaka University School of Medicine
2001 Professor in the Department of Physiology at Keio University School of Medicine
2015 Dean of Keio University School of Medicine
2017 Visiting Professor at Peking University School of Medicine
2021 Chairman of the Board of the Japan Society for Regenerative Medicine